Association of Intracranial Hemorrhage Risk With Non–Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis

Eitemau Tebyg

• Major bleeding risk with non‐vitamin K antagonist oral anticoagulant vs. aspirin in heart failure: network meta‐analysis
  gan: Huang, Wen‐Yi, et al.
  Cyhoeddwyd: (2020)
• Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non–vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
  gan: Tsai, Chuan-Tsai, et al.
  Cyhoeddwyd: (2020)
• Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused Review
  gan: Arbit, Boris, et al.
  Cyhoeddwyd: (2015)
• Characteristics of Symptomatic Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulant Therapy
  gan: Akiyama, Hisanao, et al.
  Cyhoeddwyd: (2015)
• Association of Intracerebral Hemorrhage Among Patients Taking Non–Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality
  gan: Inohara, Taku, et al.
  Cyhoeddwyd: (2018)